(Q36839668)

16 August 2017

1 reference

title

Dihydropyridine calcium channel antagonists in the management of hypertension (English)

1 reference

16 August 2017

3

Biff F Palmer

1 reference

16 August 2017

Benjamin J Epstein

1

1 reference

PubMed ID

17547473

16 August 2017

Katherine Vogel

series ordinal

2

1 reference

16 August 2017

1 January 2007

1 reference

16 August 2017

1 reference

16 August 2017

67

1 reference

16 August 2017

9

1 reference

16 August 2017

1309-1327

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200767090-00005

16 August 2017

0 references

cites work

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200767090-00005

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200767090-00005

Nifedipine. Dose-related increase in mortality in patients with coronary heart disease

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200767090-00005

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA).

21 January 2018

1 reference

12 December 2020

The risk of myocardial infarction associated with antihypertensive drug therapies

1 reference

12 December 2020

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

12 December 2020

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

12 December 2020

Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial

1 reference

12 December 2020

Post-marketing surveillance of lisinopril in general practice in the UK

1 reference

12 December 2020

Effect of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers on the rate of new-onset diabetes mellitus: a review and pooled analysis

1 reference

12 December 2020

Angiotensin receptor blockers versus ACE inhibitors: prevention of death and myocardial infarction in high-risk populations

1 reference

12 December 2020

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

1 reference

12 December 2020

Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical t

1 reference

12 December 2020

Comparative evaluation of enalapril and hydrochlorothiazide in elderly patients with mild to moderate hypertension

1 reference

12 December 2020

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial

1 reference

12 December 2020

Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes

1 reference

12 December 2020

Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group

1 reference

12 December 2020

Hypertension in blacks

1 reference

12 December 2020

Regional and racial differences in response to antihypertensive medication use in a randomized controlled trial of men with hypertension in the United States. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

1 reference

12 December 2020

Practice Guidelines For Primary Care Physicians

1 reference

12 December 2020

Epidemiologic review of the calcium channel blocker drugs. An up-to-date perspective on the proposed hazards

1 reference

12 December 2020

Safety of calcium antagonists: dissecting the evidence

1 reference

12 December 2020

Do calcium channel blockers increase the risk of cancer?

1 reference

12 December 2020

Adverse prognostic significance of new diabetes in treated hypertensive subjects

1 reference

12 December 2020

Angiotensin-converting-enzyme inhibition in stable coronary artery disease

1 reference

12 December 2020

Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis

1 reference

12 December 2020

Vasodilatory edema: a common side effect of antihypertensive therapy

1 reference

12 December 2020

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

12 December 2020

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial

1 reference

12 December 2020

Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: a critical analysis based on 100 studies

1 reference

12 December 2020

The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients

1 reference

12 December 2020

Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis

1 reference

12 December 2020

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial

1 reference

12 December 2020

Blood pressure reduction is not the only determinant of outcome

1 reference

12 December 2020

Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

1 reference

12 December 2020

What have we learned from the current trials?

1 reference

12 December 2020

A randomized, double-blind, active-controlled, parallel-group comparison of valsartan and amlodipine in the treatment of isolated systolic hypertension in elderly patients: the Val-Syst study

1 reference

12 December 2020

Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial.

1 reference

12 December 2020

Cerebroprotection mediated by angiotensin II: a hypothesis supported by recent randomized clinical trials

1 reference

12 December 2020

Time trends in high blood pressure control and the use of antihypertensive medications in older adults: the Cardiovascular Health Study.

1 reference

12 December 2020

When does new onset diabetes resulting from antihypertensive therapy increase cardiovascular risk

1 reference

12 December 2020

Combination therapy of amlodipine/benazepril versus monotherapy of amlodipine in a practice-based setting

1 reference

12 December 2020

A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks

1 reference

12 December 2020

Can the renin-angiotensin system protect against stroke? A focus on angiotensin II receptor blockers

1 reference

12 December 2020

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

1 reference

12 December 2020

Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks

1 reference

12 December 2020

Renoprotective properties of angiotensin receptor blockers beyond blood pressure lowering

1 reference

12 December 2020

Combination therapy with AT(1)-receptor blockers

1 reference

12 December 2020

Effect of an angiotensin II type 1 receptor blocker, valsartan, on neurohumoral factors in patients with hypertension: comparison with a long-acting calcium channel antagonist, amlodipine

1 reference

12 December 2020

The Verapamil in Hypertension and Atherosclerosis Study (VHAS): results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness

1 reference

12 December 2020

Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial

1 reference

12 December 2020

Comparison of antihypertensive effects of an angiotensin-converting enzyme inhibitor, a calcium antagonist and a diuretic in patients with hypertension not controlled by angiotensin receptor blocker monotherapy.

1 reference

12 December 2020

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

1 reference

12 December 2020

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

1 reference

12 December 2020

Fifty years of Framingham Study contributions to understanding hypertension

1 reference

12 December 2020

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

1 reference

12 December 2020

Use of calcium channel blockers and risk of hospitalized gastrointestinal tract bleeding

1 reference

12 December 2020

FEVER study: a trial further supporting the concept of a blood pressure-independent stroke protective effect by dihydropyridines

1 reference

12 December 2020

Antihypertensive, antiproteinuric therapy and myocardial infarction and stroke prevention

1 reference

12 December 2020

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

1 reference

12 December 2020

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

1 reference

12 December 2020

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

1 reference

12 December 2020

Amlodipine Better Than Lisinopril?

1 reference

12 December 2020

Safety of long-acting dihydropyridine calcium channel blockers in hypertensive patients

1 reference

12 December 2020

Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old.

1 reference

12 December 2020

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

12 December 2020

Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

1 reference

12 December 2020

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

1 reference

12 December 2020

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

12 December 2020

Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial

1 reference

12 December 2020

Novel vascular biology of third-generation L-type calcium channel antagonists: ancillary actions of amlodipine

1 reference

12 December 2020

Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial

1 reference

12 December 2020

How do thiazide and thiazide-like diuretics lower blood pressure?

1 reference

12 December 2020

Systematic review of combined angiotensin-converting enzyme inhibition and angiotensin receptor blockade in hypertension

1 reference

12 December 2020

Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats

1 reference

12 December 2020

Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs

1 reference

12 December 2020

Angiotensin-receptor blockers and diuretics--advantages of combination

1 reference

12 December 2020

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

12 December 2020

Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis

1 reference

12 December 2020

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

1 reference

12 December 2020

Calcium-channel blockade and incidence of cancer in aged populations

1 reference

12 December 2020

Changes in antihypertensive prescribing during US outpatient visits for uncomplicated hypertension between 1993 and 2004.

1 reference

12 December 2020

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

12 December 2020

Case-control study on colon cancer regarding previous diseases and drug intake.

1 reference

12 December 2020

The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial: outcomes in patients receiving monotherapy

1 reference

12 December 2020

Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy

1 reference

12 December 2020

Disturbances in renal autoregulation and the susceptibility to hypertension-induced chronic kidney disease.

1 reference

12 December 2020

Calcium channel blockers, apoptosis and cancer: is there a biologic relationship?

1 reference

12 December 2020

Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial

1 reference

12 December 2020

Thiazide diuretics, potassium, and the development of diabetes: a quantitative review

1 reference

12 December 2020

Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data.

1 reference

12 December 2020

Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis

1 reference

12 December 2020

2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension

1 reference

12 December 2020

10.2165/00003495-200767090-00005

Identifiers

DOI

1 reference

PubMed ID

17547473

Dimensions Publication ID

16 August 2017

0 references

1 reference

PubMed ID

17547473